Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
01 June 2018Website:
http://grail.comNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Tue, 02 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
What type of business is GRAIL LLC?
GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.
What sector is GRAIL LLC in?
GRAIL LLC is in the Healthcare sector
What industry is GRAIL LLC in?
GRAIL LLC is in the Diagnostics & Research industry
What country is GRAIL LLC from?
GRAIL LLC is headquartered in United States
When did GRAIL LLC go public?
GRAIL LLC initial public offering (IPO) was on 01 June 2018
What is GRAIL LLC website?
https://grail.com
Is GRAIL LLC in the S&P 500?
No, GRAIL LLC is not included in the S&P 500 index
Is GRAIL LLC in the NASDAQ 100?
No, GRAIL LLC is not included in the NASDAQ 100 index
Is GRAIL LLC in the Dow Jones?
No, GRAIL LLC is not included in the Dow Jones index
When does GRAIL LLC report earnings?
The next expected earnings date for GRAIL LLC is 30 August 2024